ALT vs CE · rev $20.0K vs rev $10.28B
Altimmune Inc (ALT) versus Celanese Corporation (CE) — a side-by-side from cached financials, not a winner call.
Altimmune Inc (ALT) is a biotechnology company listed on US.
Celanese Corporation (CE) is a chemicals company listed on US.
Latest reported ALT revenue for 2024-12-31 was $20.0K. Net income was -$95.1M. Revenue was down 95.3% from 2023-12-31 to 2024-12-31. ALT currently screens at market cap $527.0M.
Latest reported CE revenue for 2024-12-31 was $10.28B. Net income was -$1.51B. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. CE currently screens at market cap $5.92B.
ALT currently screens at market cap $527.0M. CE currently screens at market cap $5.92B.
Not investment advice. Open the ALT and CE stock pages for the full models.
Not investment advice.